|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.75 HKD | +1.20% |
|
+3.77% | -0.72% |
| 06-16 | Novo Nordisk to seek approval soon to sell Wegovy pill in China | RE |
| 06-11 | Race to launch weight-loss pill heats up as Novo wins UK approval | RE |
| Market Cap | 112B 130B 16.61B 14.33B 13.17B 12.4B 23.29B 1,567B 23.49B 156B 60.77B 769B 62.32B 60.99B 2,661B | P/E 2026 * |
48x | P/E 2027 * | 30.3x |
|---|---|---|---|---|---|
| Enterprise Value | 95.56B 111B 14.14B 12.2B 11.22B 10.56B 19.84B 1,334B 20B 133B 51.75B 655B 53.07B 51.94B 2,266B | EV / Sales 2026 * |
5.09x | EV / Sales 2027 * | 4.17x |
| Free-Float |
93.74% | Yield 2026 * |
-
| Yield 2027 * | 0.06% |
Last Transcript: Innovent Biologics, Inc.
| 1 day | +1.14% | ||
| 1 week | +3.77% | ||
| Current month | -9.18% | ||
| 1 month | -5.73% | ||
| 3 months | -10.78% | ||
| 6 months | -7.17% | ||
| Current year | -0.72% |
| 1 week | 72.5 |  | 79.25 |
| 1 month | 69.55 | | 86.15 |
| Current year | 69.55 | | 93.8 |
| 1 year | 69.55 | | 109.1 |
| 3 years | 27.3 | | 109.1 |
| 5 years | 18.06 | | 109.1 |
| 10 years | 14 | | 109.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 62 | 27/04/2011 |
Fei You
DFI | Director of Finance/CFO | 47 | 04/02/2024 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CHM | Chairman | 62 | 27/04/2011 |
Charles Cooney
BRD | Director/Board Member | 81 | 17/10/2015 |
Hao Xi Ede
BRD | Director/Board Member | 67 | 03/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-13 | Other | Director | -43,431 | 0.0025% | ||
| 03-29 | Other | Chief Executive Officer | 1,863,000 | 0.1074% | ||
| 03-29 | Other | Chief Executive Officer | 371,747 | 0.0214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.20% | +3.77% | -3.69% | +112.64% | 16.61B | |
| -1.11% | +1.04% | +19.47% | -22.36% | 61.85B | |
| +0.96% | -4.54% | +59.60% | +194.24% | 55.69B | |
| +2.78% | +37.00% | +37.00% | +37.00% | 41.88B | |
| +0.98% | +0.63% | -55.41% | -62.06% | 36.15B | |
| +1.56% | +2.28% | +56.98% | -33.22% | 29.33B | |
| +11.55% | +34.38% | +141.88% | -51.99% | 24.52B | |
| -0.76% | -6.07% | +43.86% | +56.56% | 19.78B | |
| +2.32% | +1.24% | +56.95% | +95.04% | 16.2B | |
| +1.13% | -0.02% | +68.18% | +348.97% | 13.2B | |
| Average | +1.02% | +4.19% | +42.48% | +67.48% | 31.52B | |
| Weighted average by Cap. | +0.85% | +3.47% | +37.59% | +49.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.78B 21.77B 2.78B 2.4B 2.2B 2.07B 3.9B 262B 3.93B 26.12B 10.17B 129B 10.43B 10.21B 445B | 22.1B 25.62B 3.27B 2.82B 2.59B 2.44B 4.59B 309B 4.63B 30.74B 11.97B 151B 12.27B 12.01B 524B |
| Net income | 2.47B 2.86B 365M 315M 290M 273M 513M 34.49B 517M 3.44B 1.34B 16.93B 1.37B 1.34B 58.56B | 3.55B 4.11B 525M 453M 416M 392M 736M 49.52B 742M 4.93B 1.92B 24.3B 1.97B 1.93B 84.08B |
| Net Debt | -16.66B -19.31B -2.46B -2.13B -1.95B -1.84B -3.46B -233B -3.49B -23.17B -9.02B -114B -9.25B -9.05B -395B | -20.13B -23.34B -2.98B -2.57B -2.36B -2.22B -4.18B -281B -4.21B -27.99B -10.9B -138B -11.18B -10.94B -477B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 75.75 $ | +1.20% | 4,631,000 |
| 17/06/26 | 74.85 $ | -2.03% | 7,660,565 |
| 16/06/26 | 76.40 $ | -1.29% | 6,706,506 |
| 15/06/26 | 77.40 $ | +1.24% | 11,959,240 |
| 12/06/26 | 76.45 $ | +4.80% | 20,243,630 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1801 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition